Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Internet Promotion Warning Letters Continue In Guidance Vacuum

This article was originally published in The Gray Sheet

Executive Summary

Counsel for OmniCorder Technologies is preparing a response to an April 18 warning letter citing Internet promotions representing the firm's BioScan system "as a stand-alone diagnostic device for breast cancer detection," the company says.

You may also be interested in...



Website Off-Label Reprints May Require Physician-Only Access, FDAer Says

Device companies disseminating peer-reviewed journal articles discussing off-label uses to health care practitioners over the Internet may need to develop security mechanisms to ensure that only those individuals could access the information, FDA says.

Website Off-Label Reprints May Require Physician-Only Access, FDAer Says

Device companies disseminating peer-reviewed journal articles discussing off-label uses to health care practitioners over the Internet may need to develop security mechanisms to ensure that only those individuals could access the information, FDA says.

Interpore Cross Cited For BonePlast Journal Ad In FDA Warning Letter

Interpore Cross may face FDA misbranding and adulteration actions if the company provides reprints of journal articles detailing use of the firm's BonePlast bone void filler with antibiotics, growth factors or other therapeutics.

Related Content

UsernamePublicRestriction

Register

MT013336

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel